Predicting the risk of venous thromboembolism events in older adults with rheumatoid arthritis after initiating targeted disease-modifying antirheumatic drugs: a comparison of the random survival forest and regularized cox regression models
CONCLUSIONS: The RSF model performed slightly better in identifying VTE in RA patients after b/tsDMARDs initiation than RegCox. Incorporating additional clinical and contextual information beyond claims data may further enhance predictive accuracy in future studies.